Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Eisner

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Chest|October 21, 2005
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care ProgramStephen Sidney, Michael Sorel, Charles P Quesenberry, et al.
COPD|April 9, 2009
The COPD severity score: a dynamic prediction tool for health-care utilizationTheodore A Omachi, Edward H Yelin, Patricia P Katz, et al.
Critical Care Medicine|January 13, 2005
Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injuryIvan W Cheng, Mark D Eisner, B Taylor Thompson, et al.
Analytical Chemistry|October 10, 2008
Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometryPeyton Jacob, Christopher Havel, Do-Hoon Lee, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2017
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trialsCarlos Iribarren, Kenneth J Rothman, Mary S Bradley, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2004
Significance of von Willebrand factor in septic and nonseptic patients with acute lung injuryLorraine B Ware, Mark D Eisner, B Taylor Thompson, et al.
Critical Care Medicine|March 28, 2009
Recent trends in acute lung injury mortality: 1996-2005Sara E Erickson, Greg S Martin, J Lucian Davis, et al.
Environmental Health : a Global Access Science Source|May 14, 2005
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary diseaseMark D Eisner, John Balmes, Patricia P Katz, et al.
The American Journal of Medicine|September 27, 2006
Risk factors for work disability in severe adult asthmaMark D Eisner, Edward H Yelin, Patricia P Katz, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2012
Omalizumab and the risk of malignancy: results from a pooled analysisWilliam Busse, Roland Buhl, Carlos Fernandez Vidaurre, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Chest|October 21, 2005
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care ProgramStephen Sidney, Michael Sorel, Charles P Quesenberry, et al.
COPD|April 9, 2009
The COPD severity score: a dynamic prediction tool for health-care utilizationTheodore A Omachi, Edward H Yelin, Patricia P Katz, et al.
Critical Care Medicine|January 13, 2005
Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injuryIvan W Cheng, Mark D Eisner, B Taylor Thompson, et al.
Analytical Chemistry|October 10, 2008
Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometryPeyton Jacob, Christopher Havel, Do-Hoon Lee, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2017
Cardiovascular and cerebrovascular events among patients receiving omalizumab: Pooled analysis of patient-level data from 25 randomized, double-blind, placebo-controlled clinical trialsCarlos Iribarren, Kenneth J Rothman, Mary S Bradley, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2004
Significance of von Willebrand factor in septic and nonseptic patients with acute lung injuryLorraine B Ware, Mark D Eisner, B Taylor Thompson, et al.
Critical Care Medicine|March 28, 2009
Recent trends in acute lung injury mortality: 1996-2005Sara E Erickson, Greg S Martin, J Lucian Davis, et al.
Environmental Health : a Global Access Science Source|May 14, 2005
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary diseaseMark D Eisner, John Balmes, Patricia P Katz, et al.
The American Journal of Medicine|September 27, 2006
Risk factors for work disability in severe adult asthmaMark D Eisner, Edward H Yelin, Patricia P Katz, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2012
Omalizumab and the risk of malignancy: results from a pooled analysisWilliam Busse, Roland Buhl, Carlos Fernandez Vidaurre, et al.
Pageof 12